Skip to Content

WATSON 409 (Lisinopril 40 mg)

Pill with imprint WATSON 409 is Yellow, Round and has been identified as Lisinopril 40 mg. It is supplied by Watson Pharmaceuticals.

Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; heart attack; heart failure; coronary artery disease (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 40 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 409

Lisinopril 40 mg WATSON 409
Lisinopril 40 mg WATSON 409  Front
Lisinopril 40 mg WATSON 409  Back
Lisinopril 40 mg WATSON 409
Lisinopril 40 mg WATSON 409


40 mg
Prescription only
Drug Class:
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
silicon dioxide
calcium phosphate dihydrate dibasic
magnesium stearate
corn starch
FD&C Yellow No. 5
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
54868-4646 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.